Skip to main content
. 2020 Jan 9;7:361. doi: 10.3389/fcell.2019.00361

FIGURE 5.

FIGURE 5

mRNA expression levels of CMTM5 in breast cancer according to different clinicopathological characteristics from the UALCAN database (∗∗P < 0.01). (A) Tumor stage, (B) nodal stage, (C) histologic subtypes, and (D) breast cancer subtypes.